Literature DB >> 27573580

Clostridium difficile colitis: pathogenesis and host defence.

Michael C Abt1, Peter T McKenney1, Eric G Pamer1.   

Abstract

Clostridium difficile is a major cause of intestinal infection and diarrhoea in individuals following antibiotic treatment. Recent studies have begun to elucidate the mechanisms that induce spore formation and germination and have determined the roles of C. difficile toxins in disease pathogenesis. Exciting progress has also been made in defining the role of the microbiome, specific commensal bacterial species and host immunity in defence against infection with C. difficile. This Review will summarize the recent discoveries and developments in our understanding of C. difficile infection and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27573580      PMCID: PMC5109054          DOI: 10.1038/nrmicro.2016.108

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  168 in total

1.  Integration of metabolism and virulence by Clostridium difficile CodY.

Authors:  Sean S Dineen; Shonna M McBride; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

2.  Functional characterization of Clostridium difficile spore coat proteins.

Authors:  Patima Permpoonpattana; Jutarop Phetcharaburanin; Anna Mikelsone; Marcin Dembek; Sisareuth Tan; Marie-Clémence Brisson; Roberto La Ragione; Alain R Brisson; Neil Fairweather; Huynh A Hong; Simon M Cutting
Journal:  J Bacteriol       Date:  2013-01-18       Impact factor: 3.490

3.  Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen.

Authors:  Mizuho Hasegawa; Takashi Yamazaki; Nobuhiko Kamada; Kazuki Tawaratsumida; Yun-Gi Kim; Gabriel Núñez; Naohiro Inohara
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

4.  Human neutrophils are activated by a peptide fragment of Clostridium difficile toxin B presumably via formyl peptide receptor.

Authors:  Sebastian D Goy; Alexandra Olling; Detlef Neumann; Andreas Pich; Ralf Gerhard
Journal:  Cell Microbiol       Date:  2015-01-26       Impact factor: 3.715

Review 5.  Crisscross regulation of cell-type-specific gene expression during development in B. subtilis.

Authors:  R Losick; P Stragier
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

6.  Riboswitches in eubacteria sense the second messenger cyclic di-GMP.

Authors:  N Sudarsan; E R Lee; Z Weinberg; R H Moy; J N Kim; K H Link; R R Breaker
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

7.  The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.

Authors:  Robert W McKee; Mihnea R Mangalea; Erin B Purcell; Erin K Borchardt; Rita Tamayo
Journal:  J Bacteriol       Date:  2013-09-13       Impact factor: 3.490

8.  Cyclic diguanylate inversely regulates motility and aggregation in Clostridium difficile.

Authors:  Erin B Purcell; Robert W McKee; Shonna M McBride; Christopher M Waters; Rita Tamayo
Journal:  J Bacteriol       Date:  2012-04-20       Impact factor: 3.490

9.  Characterisation of Clostridium difficile biofilm formation, a role for Spo0A.

Authors:  Lisa F Dawson; Esmeralda Valiente; Alexandra Faulds-Pain; Elizabeth H Donahue; Brendan W Wren
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

10.  Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

Authors:  Glen P Carter; Anjana Chakravorty; Tu Anh Pham Nguyen; Steven Mileto; Fernanda Schreiber; Lucy Li; Pauline Howarth; Simon Clare; Bliss Cunningham; Susan P Sambol; Adam Cheknis; Iris Figueroa; Stuart Johnson; Dale Gerding; Julian I Rood; Gordon Dougan; Trevor D Lawley; Dena Lyras
Journal:  MBio       Date:  2015-06-02       Impact factor: 7.867

View more
  151 in total

1.  Misoprostol protects mice against severe Clostridium difficile infection and promotes recovery of the gut microbiota after antibiotic perturbation.

Authors:  Joseph P Zackular; Leslie Kirk; Bruno C Trindade; Eric P Skaar; David M Aronoff
Journal:  Anaerobe       Date:  2019-06-17       Impact factor: 3.331

2.  First case of periprosthetic joint infection due to Clostridioides difficile in China.

Authors:  Yang Song; Hong Yi Shao; Xiang Cheng; Yu Guo
Journal:  BMC Infect Dis       Date:  2021-05-21       Impact factor: 3.090

Review 3.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

4.  Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms.

Authors:  Jemila C Kester; Douglas K Brubaker; Jason Velazquez; Charles Wright; Douglas A Lauffenburger; Linda G Griffith
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

5.  Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice.

Authors:  Xiaolun Sun; Kathryn Winglee; Raad Z Gharaibeh; Josee Gauthier; Zhen He; Prabhanshu Tripathi; Dorina Avram; Steven Bruner; Anthony Fodor; Christian Jobin
Journal:  Gastroenterology       Date:  2018-02-01       Impact factor: 22.682

Review 6.  Probiotics for prevention of Clostridium difficile infection.

Authors:  John P Mills; Krishna Rao; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2018-01       Impact factor: 3.287

7.  A Xylose-Inducible Expression System and a CRISPR Interference Plasmid for Targeted Knockdown of Gene Expression in Clostridioides difficile.

Authors:  Ute Müh; Anthony G Pannullo; David S Weiss; Craig D Ellermeier
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

8.  Clostridium difficile Infection and the Role of Adaptive Immunity in the Microbiome.

Authors:  Monika Fischer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-05

9.  The chaperonin TRiC/CCT is essential for the action of bacterial glycosylating protein toxins like Clostridium difficile toxins A and B.

Authors:  Marcus Steinemann; Andreas Schlosser; Thomas Jank; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

10.  Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile.

Authors:  Erika van Eijk; Ilse M Boekhoud; Ed J Kuijper; Ingrid M J G Bos-Sanders; George Wright; Wiep Klaas Smits
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.